Clinical cases of myocardial infarction in pregnant women: the role of hereditary thrombophilia

Cover Page


Cite item

Full Text

Abstract

Acute myocardial infarction during pregnancy is a threatening complication with high maternal and perinatal mortality. According to the literature, hereditary thrombophilia is commonly associated with obstetric disorders and susceptibility to venous thrombosis, whereas arterial part of the vasculature, including coronary, is rarely involved. The article describes two clinical cases of pregnant women with acute myocardial infarction and post-infarction cardiosclerosis, in whom hereditary thrombophilia, associated with the gene PAI-1-675 polymorphism, was diagnosed. Mothers of both patients had suffered myocardial infarction at a young age, while past history of only one pregnant woman was remarkable for multiple perinatal losses. Myocardial infarction may manifest with intense headache mirroring systemic angiospasm.

Based on the clinical observations of acute myocardial infarction in pregnancy, one could conclude that measurements of troponin levels that might be false negative should be done repeatedly, while the signs of transmural myocardial injury at ECG can evolve into those of an intramural myocardial infarction. Miscarriage and fetoplacental insufficiency have been found in the patients with combination of hereditary thrombophilia and myocardial injury. Coronary artery damage in pregnant women can be the result of hereditary thrombophilia, most often associated with the PAI-1-675 gene polymorphism, as well as its combination with the heterozygous state of other genes.

The absence of past perinatal losses and venous thromboembolism in pregnant women with myocardial infarction does not exclude hereditary thrombophilia, and additional work-up of the patient and the proband family is mandatory to exclude the underlying pathology. The course of myocardial infarction may not require an intracoronary intervention, and treatment may consist of non-fractionated or low molecular weight heparin and calcium antagonists.

About the authors

S. R. Mravyan

Moscow Regional Scientific Research Institute for Obstetrics and Gynecology

Author for correspondence.
Email: sergeymrav@list.ru
ORCID iD: 0000-0002-9591-8433

Sergey R. Mravyan - MD, PhD, Leading Research Fellow, Obstetrical and Physiological Department.

9-88 Krasnoproletarskaya ul., Moscow, 127006, Tel.: +7 (495) 621 71 39

Россия

T. S. Kovalenko

Moscow Regional Scientific Research Institute for Obstetrics and Gynecology

Email: 1akmoniiag@mail.ru
ORCID iD: 0000-0001-8995-6727

Tatiana S. Kovalenko - MD, PhD, Leading Research Fellow, Obstetrical and Physiological Department.

22a Pokrovka ul., Moscow, 101000, Tel.: +7 (495) 621 71 39

Россия

I. O. Shuginin

Moscow Regional Scientific Research Institute for Obstetrics and Gynecology

Email: 1akmoniiag@mail.ru
ORCID iD: 0000-0002-9456-8275

Igor O. Shuginin - MD, PhD, Head of Obstetrical and Physiological Department.

22a Pokrovka ul., Moscow, 101000; Tel.: +7 (495) 621 71 39

Россия

T. S. Budykina

Moscow Regional Scientific Research Institute for Obstetrics and Gynecology

Email: budyt@mail.ru
ORCID iD: 0000-0001-9873-2354

Tatiana S. Budykina - MD, PhD, Head of Clinical Diagnostic Laboratory.

22a Pokrovka ul., Moscow, 101000; Tel.: +7 (495) 621 71 39

Россия

S. I. Fedorova

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru
ORCID iD: 0000-0003-2957-3403

Svetlana I. Fedorova - MD, PhD, Head of Department of Functional Diagnostics.

61/2 Shchepkina ul., Moscow, 129110; Tel.: +7 (499) 681 55 71

Россия

References

  1. Tripathi B, Kumar V, Pitiliya A, Arora S, Sharma P, Shah M, Atti V, Ram P, Patel B, Patel NJ, Tripathi A, Savani S, Wojtaszek E, Patel T, Deshmukh A, Figueredo V, Gopalan R. Trends in Incidence and Outcomes of Pregnancy-Related Acute Myocardial Infarction (From a Nationwide Inpatient Sample Database). Am J Cardiol. 2019;123(8):1220-7. doi: 10.1016/j.amjcard.2019.01.030.
  2. Elkayam U, Jalnapurkar S, Barakkat MN, Khatri N, Kealey AJ, Mehra A, Roth A. Pregnancy-associated acute myocardial infarction: a review of contemporary experience in 150 cases between 2006 and 2011. Circulation. 2014;129(16):1695-702. doi: 10.1161/CIRCU-LATIONAHA.113.002054.
  3. Dtuski D, Mierzynski R, Poniedzialek-Czajkowska E, Leszczynska-Gorzelak B. Adverse pregnancy outcomes and inherited thrombophilia. J Perinat Med. 2018;46(4):411-7. doi: 10.1515/jpm-2017-0059.
  4. Баринов СВ, Полтанова АА, Плехо РМ, Стариков НВ, Кролевец ЭН, Медянникова ИВ, Тирская ЮИ, Шамина ИВ, Ковалева ЮА, Шлапаков ОВ. Клиническое наблюдение родоразрешения при многоплодной беременности пациентки с крупноочаговым инфарктом миокарда в анамнезе и стентированием коронарной артерии. Российский вестник акушера-гинеколога. 2019;19(1):76-9. doi: 10.17116/rosakush20191901176.
  5. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol. 2008;52(3):171-80. doi: 10.1016/j.jacc.2008.03.049.
  6. Ito H, Taylor L, Bowman M, Fry ET, Hermiller JB, Van Tassel JW. Presentation and therapy of spontaneous coronary artery dissection and comparisons of postpartum versus nonpost-partum cases. Am J Cardiol. 2011;107(11): 1590-6. doi: 10.1016/j.amjcard.2011.01.043.
  7. Al-Sadawi M, Shaikh S, Marmur JD, Salcicci-oli L, Kariyanna PT, McFarlane IM. Post-par-tum spontaneous coronary artery dissection: a case report. Am J Med Case Rep. 2018;6(10): 218-21. doi: 10.12691/ajmcr-6-10-6.
  8. Elkayam U, Jalnapurkar S, Barakkat MN, Kha-tri N, Kealey AJ, Mehra A, Roth A. Pregnancy-associated acute myocardial infarction: a review of contemporary experience in 150 cases between 2006 and 2011. Circulation. 2014;129(16):1695-702. doi: 10.1161/CIRCU-LATIONAHA.113.002054.
  9. Lindor RA, Tweet MS, Goyal KA, Lohse CM, Gulati R, Hayes SN, Sadosty AT. Emergency Department Presentation of Patients with Spontaneous Coronary Artery Dissection. J Emerg Med. 2017;52(3):286-91. doi: 10.1016/j.jemermed.2016.09.005.
  10. Hossain N, Shamsi T, Soomro N. Frequency of thrombophilia in patients with adverse pregnancy outcome. J Pak Med Assoc. 2005;55(6): 245-7.
  11. Галайко МВ, Рыбина ОВ, Литвиненко МС, Климов ЮВ, Альтшулер БЮ, Губкин АВ. Тромбофилия и беременность. Клиническая онкогематология. 2017;10(3): 409-22. doi: 10.21320/2500-2139-2017-103-409-422.
  12. Trasca LF, Patrascu N, Bruja R, Munteanu O, Cirstoiu M, Vinereanu D. Therapeutic Implications of Inherited Thrombophilia in Pregnancy. Am J Ther. 2019;26(3):e364-74. doi: 10.1097/MJT.0000000000000985.
  13. Bohiltea RE, Turcan N, Muresian H, Condu S, Bratila E, Cirstoiu MM. Postpartum Aortic Bifurcation Thrombosis on the Background of Thrombophilic Disorder. Maedica (Bucur). 2016;11(3):241-4.
  14. Фазлиахметова АГ, Богданов ЭИ. Тромбофилия и инсульт. Практическая медицина. 2016;4-2(96):133-6.
  15. Кокорин ВА, Кочмарева ЕА, Варданян АГ, Кондрашова ЕА, Хохлова НВ, Дорошенко ДА, Каширин ВВ, Конышева ОВ. Некомпактный миокард левого желудочка у беременной пациентки с наследственной тромбофилией: разбор клинического случая. Медицинский вестник Северного Кавказа. 2017;12(2): 222-5. doi: 10.14300/mnnc.2017.12064.
  16. Couto E, Nomura ML, Barini R, Pinto e Silva JL. Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations. Sao Paulo Med J. 2005;123(6):286-8. doi: 10.1590/s1516-31802005000600007.
  17. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342(6):374-80. doi: 10.1056/NEJM200002103420602.
  18. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J. 2003;146(6):948-57. doi: 10.1016/S0002-8703(03)00519-2.
  19. Chen H, Nie S, Lu M. Association between plasminogen activator inhibitor-1 gene polymorphisms and recurrent pregnancy loss: a systematic review and meta-analysis. Am J Reprod Immunol. 2015;73(4):292-300. doi: 10.1111/aji.12321.
  20. Jung RG, Motazedian P, Ramirez FD, Simard T, Di Santo P, Visintini S, Faraz MA, Labinaz A, Jung Y, Hibbert B. Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and me-ta-analysis. Thromb J. 2018;16:12. doi: 10.1186/s12959-018-0166-4.
  21. Song C, Burgess S, Eicher JD, O'Donnell CJ, Johnson AD. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease. J Am Heart Assoc. 2017;6(6):e004918. doi: 10.1161/JAHA.116.004918.
  22. James AH, Jamison MG, Biswas MS, Brancazio LR, Swamy GK, Myers ER. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation. 2006;113(12): 1564-71. doi: 10.1161/CIRCULATIONA-HA.105.576751.
  23. Kealey A. Coronary artery disease and myocardial infarction in pregnancy: a review of epidemiology, diagnosis, and medical and surgical management. Can J Cardiol. 2010;26(6):185-9. doi: 10.1016/s0828-282x(10)70397-4.
  24. Мравян СР, Петрухин ВА, Давыдова ТВ, Будыкина ТС, Тишенина РС, Пронина ВП, Гришин ВЛ. Особенности ведения беременности после множественного стентирования коронарных артерий. Клиническая медицина. 2012;90(9):69-74.
  25. Макацария АД., Бицадзе ВО. Антифосфолипидный синдром, генетические тромбофилии в патогенезе основных форм акушерской патологии. Русский медицинский журнал. 2006;S0:2-10.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Mravyan S.R., Kovalenko T.S., Shuginin I.O., Budykina T.S., Fedorova S.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies